Mallinckrodt Pharmaceuticals (NYSE:MNK) said yesterday that it received a subpoena from the U.S. Dept. of Justice requesting information related to its marketing practices and sales of opioids.
The company, which manufactures only generic and non-promoted branded opioids, said that it has worked to prevent misuse and diversion of its products, pointing to efforts like its testimonies on behalf of the prosecution in drug diversion cases.
Get the full story at our sister site, Drug Delivery Business News.
The post DOJ subpoenas Mallinckrodt over opioids appeared first on MassDevice.